US stocks stage limited recovery after $3.2 trillion selloff

NVDA fell sharply by over 10% in 24 hours to 186.68 and is trading below its SMA20/SMA50; the short-term trend is weak. With RSI at 35.97, it is approaching oversold territory, while MACD is in negative territory but slightly above its signal line, indicating that selling pressure has somewhat eased. Although the phrase 'limited recovery' in the news headline points to dip buying in the broader market, NVDA's own momentum remains fragile. In the 1-3 day outlook, a sideways-choppy session with rebound buying is possible; without a sustained return above 192 (SMA20), it is difficult to call the direction upward. Therefore, a neutral stance should be maintained, keeping high volatility in mind.

AMD experienced strong selling pressure, dropping 8.9% in 24 hours and closing at 449, just below the SMA20 (450.5). The RSI is at 45.8, in neutral territory with no oversold signal; the MACD is negative but above the signal line, indicating weakening downward momentum. The news headline points to a general market recovery but contains no AMD-specific catalyst, so its impact may be limited. With the SMA50 (489) clearly above, the medium-term trend remains downward. In the short term, a sideways-to-choppy range is expected unless the 450-455 resistance is breached.

TSM has sharply declined 7.7% in the last 24 hours, falling below both its 20-day and 50-day simple moving averages (SMA20 and SMA50). However, the MACD remains above its signal line with the histogram turning positive, and the RSI at 42 is still far from oversold territory. Although the news headline points to a broader market recovery, it does not contain a TSM-specific catalyst, so the impact may be limited. In the short term, some bargain-hunting buying interest may emerge around 375, but the SMA20 resistance at 378 is critical. To confirm a recovery, volume and a close above 378 should be monitored. Given the directional uncertainty, a neutral stance is appropriate.

AVGO fell sharply by 11.7% over the past 24 hours to 293.32, with its RSI at 29.7 approaching oversold territory. MACD is negative and below the signal line, and the price is clearly below both SMA20 and SMA50; the short-term trend is weak. Although the news headline points to a limited recovery in the broader market, this is not an AVGO-specific catalyst and does not explain the main reason for the decline. Oversold conditions could set the stage for bargain-hunting rebounds, but momentum remains downward, leaving direction uncertain. A neutral outlook and moderate confidence are therefore appropriate for the 1-3 day horizon.